CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 29, 2019-- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, today announced that John P. Butler, President and Chief Executive Officer of Akebia, will participate in the following investor conferences:

• The Jefferies 2019 Healthcare Conference on Tuesday, June 4^th at 3:00 p.m. Eastern Time at the Grand Hyatt New York.
• The Raymond James Life Sciences and MedTech Conference on Wednesday, June 19^th at 10:55 a.m. Eastern Time at the Lotte New York Palace.

A live webcast of the presentations will be available on the company’s website at www.akebia.com. A replay of the webcast will be available on Akebia’s website following the conference.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190529005213/en/

Source: Akebia Therapeutics, Inc.

Kristen K. Sheppard, Esq
VP, Investor Relations
ksheppard@akebia.com